KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction. Novo Nordisk A/S and KBP...
Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone
Novo Nordisk’s $2.7 Billion Drug Discovery Collaboration with Valo Health
Ropes & Gray advised Novo Nordisk on the deal. Novo Nordisk A/S and Valo Health, Inc. announced they have entered into an agreement to discover and...
Novo Nordisk’s EUR154 Million Acquisition of a Majority Stake in Biocorp
McDermott advised Biocorp Production SA on its proposed acquisition by Novo Nordisk, while Novo Nordisk A/S was advised by Bird & Bird. Novo Nordisk A/S and...
Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
Novo Nordisk’s Acquisition of Dicerna Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom advised Dicerna Pharmaceuticals on the deal. Davis Polk & Wardwell advised Evercore. Dicerna Pharmaceuticals, Inc., has entered into a definitive agreement...